ANDE News Alert The Andersons (ANDE) 54.12 11/13/2014 17:15:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
The Andersons (ANDE) 54.12 $ANDE

Nasdaq stocks posting largest percentage decreases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
TNGO: 12.63 (-0.32), PRSC: 36.49 (-1.02), FNGN: 32.36 (+0.08), LACO: 7.11 (+0.04), MSON: 11.83 (-0.17), SLXP: 96.99 (+1.44), FNHC: 25.05 (-0.73), MDRX: 12.46 (+0.51), PCMI: 8.94 (+0.14), UBNT: 28.72 (-0.28), PFMT: 6.85 (-0.07), ICPT: 158.86 (-4.10), ANDE: 54.12 (-0.81), ACTA: 16.71 (-0.36)

Andersons (ANDE) Plunges as Q3 Earnings Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 3:20PM CST
The Andersons Inc. (ANDE) plunged 18% on reporting a 3% decline in Q3 earnings to 59 cents per share, way short of the Zacks Consensus Estimate of 76 cents.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

MRC Global (MRC) Beats Q3 Earnings on Record Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 2:30PM CST
MRC Global Inc. (MRC) reported improved results for the third quarter of 2014, beating the Zacks Consensus Estimate for both revenues and earnings.
AA: 16.74 (-0.14), MRC: 21.55 (-0.14), ANDE: 54.12 (-0.81), MMP: 84.56 (-0.91)

Andersons (ANDE) Is Today's Dead Cat Bounce Stock
at The Street - Fri Nov 07, 9:23AM CST
Trade-Ideas LLC identified Andersons (ANDE) as a "dead cat bounce" (down big yesterday but up big today) candidate
ANDE: 54.12 (-0.81)

The Andersons' (ANDE) CEO Mike Anderson on Q2 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 11:32PM CST

ANDE: 54.12 (-0.81)

Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 11:47AM CST

SWIR: 38.96 (+1.66), PERI: 5.79 (-0.22), RMGN: 1.09 (-0.03), WWWW: 16.29 (+0.28), ASTI: 2.11 (+0.09), GNW: 9.30 (+0.50), SNMX: 5.61 (-0.23), ALXA: 1.60 (unch), PLUS: 67.25 (-1.98), PPO: 52.91 (+0.12), NSM: 27.25 (-0.26), AEZS: 0.59 (-0.02), WAC: 16.58 (-0.26), KATE: 28.80 (-0.38), CGG: 8.69 (+0.10), ANDE: 54.12 (-0.81), ENG: 1.89 (-0.01), PLNR: 6.67 (-0.48), ALG: 44.79 (-2.72), SZYM: 3.44 (-0.08)

Cosan Q3 Earnings Fall on Weak Revenues and Forex Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 10:50AM CST
Cosan Limited (CZZ) failed to gain momentum in third-quarter 2014, posting weaker year-over-year results. Net income plummeted approximately 92.6% to R$15.2 million (US$6.7 million) from R$205.9 million (US$90.3 million) in the year-ago quarter.
CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), PEG: 39.28 (-0.44), ANDE: 54.12 (-0.81)

Andersons misses Street 3Q forecasts
Automated Insights - Wed Nov 05, 6:31PM CST
MAUMEE, Ohio (AP) _ The Andersons Inc. (ANDE) on Wednesday reported third-quarter profit of $16.8 million.
ANDE: 54.12 (-0.81)

Andersons misses by $0.17, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 5:26PM CST

ANDE: 54.12 (-0.81)

The Andersons, Inc. Reports Third Quarter Results
CNW Group - Wed Nov 05, 5:00PM CST
The Andersons, Inc. (Nasdaq: ANDE) today announces financial results for the third quarter ended September 30, 2014.
ANDE: 54.12 (-0.81)

The Andersons (ANDE) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:55AM CST

ANDE: 54.12 (-0.81)

Notable earnings after Wednesday’s close
Seeking Alpha - at Seeking Alpha - Tue Nov 04, 4:35PM CST

CXO: 114.97 (-0.56), CODI: 17.06 (-0.11), EXXI: 6.84 (-0.13), JCOM: 55.33 (-0.68), ATSG: 8.32 (-0.12), GPOR: 51.56 (-1.52), ENS: 59.88 (-0.23), ECYT: 6.33 (-0.15), ALNY: 99.33 (-0.52), KGC: 2.52 (+0.06), GSM: 18.00 (-0.78), BKD: 33.07 (+0.19), DK: 29.79 (-1.67), AR: 53.18 (-2.33), IL: 9.57 (+0.01), DVR: 0.14 (-0.08), IO: 2.58 (-0.13), DEPO: 14.78 (+0.13), ETE: 60.92 (-1.03), AVG: 19.27 (-0.21), CSOD: 28.55 (+0.14), GNW: 9.30 (+0.50), ECOL: 42.03 (-2.35), BWC: 30.20 (-0.23), CPE: 6.04 (-0.19), FNV: 50.18 (-0.89), CTL: 40.92 (+0.42), ASH: 112.85 (-0.06), ENSG: 40.53 (-0.17), CLR: 52.60 (-1.67), ACAS: 15.25 (-0.05), G: 17.81 (-0.10), BREW: 13.72 (+0.08), AWK: 51.87 (-0.48), CVG: 21.25 (-0.14), AREX: 11.46 (-0.48), HTCH: 3.57 (-0.13), ETP: 63.63 (-0.91), ABTL: 10.72 (-0.57), FMI: 24.95 (-0.15), DPM: 51.23 (-0.62), BCOR: 14.47 (-0.12), CDE: 3.80 (-0.05), DRYS: 1.41 (-0.02), KW: 26.99 (-0.40), BALT: 3.16 (-0.18), ATO: 54.51 (+0.61), EXAR: 8.75 (-0.12), ACLS: 2.15 (+0.01), INWK: 7.48 (-0.28), ALSK: 1.35 (-0.03), CF: 267.12 (+0.74), EFC: 21.75 (unch), BIOS: 5.86 (+0.09), DYN: 33.22 (-0.92), DATA: 82.59 (-0.86), ANDE: 54.12 (-0.81), HOLX: 26.52 (-0.03), CBS: 51.87 (+0.30)

Andersons Buys 2 Grain Companies to Expand Corn Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 21, 4:15PM CDT
Andersons (ANDE) has acquired the assets of United Grain and Keller Grain.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

Dividend Contenders: 34 Increases Expected By December 31
David Fish - at Seeking Alpha - Sat Oct 18, 5:44PM CDT

CASS: 49.03 (-0.40), MATW: 45.95 (-0.17), SEIC: 39.57 (+0.10), SFG: 68.63 (+0.06), NKE: 96.12 (+0.31), NKSH: 30.40 (-1.29), MDU: 25.00 (-0.42), SJI: 57.19 (-0.87), AEL: 27.11 (+0.26), MSM: 83.74 (-0.77), UMBF: 59.59 (-0.89), AAN: 27.51 (-0.09), YORW: 21.87 (-0.29), SYK: 88.84 (+0.26), ECL: 112.95 (-0.03), AXS: 49.64 (+0.31), WHG: 63.75 (-0.37), JJSF: 104.29 (-0.04), AROW: 27.18 (-0.26), LECO: 73.95 (-0.65), BRO: 31.90 (-0.13), WABC: 50.05 (-0.92), UBA: 22.08 (+0.07), RGLD: 64.63 (-1.03), ANDE: 54.12 (-0.81), UTMD: 59.27 (-0.69), EIX: 61.68 (-0.72), LG: 50.50 (-0.43), PB: 60.28 (-0.81), VGR: 21.54 (-0.36)

Syngenta's Q3 Sales Rise Y/Y, 2014 Sales Growth Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:59AM CDT
Syngenta AG (SYT), after completing third-quarter 2014, has maintained its full year aggregated sales growth rate of 6%.
BG: 88.75 (+0.24), SYT: 65.25 (+1.54), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)

The Andersons Purchases Two Grain Companies in Texas
CNW Group - Fri Oct 17, 8:00AM CDT
The Andersons, Inc. (Nasdaq: ANDE) announces today it has finalized its purchase of the majority of the assets of two San Antonio, Texas-based, food grade corn companies, United Grain, LLC and Keller Grain, Inc.
ANDE: 54.12 (-0.81)

Andersons (ANDE) Buys Assets of Auburn Bean and Grain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 11:20AM CDT
Andersons (ANDE) has acquired the assets of Auburn Bean and Grain.
BG: 88.75 (+0.24), CZZ: 9.37 (-0.20), LMNR: 25.56 (-0.16), ANDE: 54.12 (-0.81)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nicely Network: A Game-Changer for B2B SaaS Marketing

Updated Category News Views 173

Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...

Continue Reading
JOIA Rose Hall Revives Jamaican Luxury Experience

Updated Category News Views 78

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 63

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading
AI Literacy Framework Unfolds at AAC&U Conference

Updated Category News Views 30

Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...

Continue Reading
Guidewire Celebrates P&C Insurance Innovators

Updated Category News Views 50

P&C Insurance Takes Center Stage If there's one thing that gets the blood pumping at a conference, it's innovation. This year, Guidewire pulled out all the stops at their Connections Conference in Las Vegas, spotlighting customer and partner triumphs in the P&C insurance sector. From Guidewire Innovation Awards to Partner Excellence Awards, the event was an ode to...

Continue Reading
Veralto Sees Strong Q3 2026 Growth, Eyes 2027 Gains

Updated Category News Views 22

Veralto's Stellar Third Quarter Performance Jumping right into the thick of it, Veralto's third quarter 2026 numbers aren't just a flash in the pan. We're talking a solid sales boost of 7.5%, reaching the magic number of $1,509 million. If you're holding NYSE:VLTO, these figures are a good look. It's not every day you see an operating profit margin hovered at an...

Continue Reading
Geolava, Vaidio, Sensoneo Triumph in Texas Pitch Contest

Updated Category News Views 48

North Texas Lights the Innovation Torch Big moves are happening in North Texas, with a pitch competition that's more than just smoke and mirrors. We're talking about an arena where regional challenges meet cutting-edge solutions, and out of a global mix, Geolava, Vaidio, and Sensoneo snagged the 2026 North Texas Connected Innovation Pitch Contest crown. It's high stakes...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 57

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Domestic Violence Laws: A Broken Shield Revealed

Updated Category News Views 24

A Look at Where Policies Stumble Life's got no script for chaos, and you'd think the laws meant to protect folks from domestic violence would at least have a solid plan. Turns out, that's not always the case. Bloomberg Law just pulled back the curtain in a stinging investigation that exposes the gaping holes in these well-meaning policies. Why spill my morning coffee over...

Continue Reading
Quaker Houghton Propels Forward with Q3 2026 Gains

Updated Category News Views 28

Quaker Houghton's Strategy Yields Positive Q3 2026 Results Imagine getting through another quarter against global economic headwinds and coming out profitable. That’s exactly what Quaker Houghton (NYSE:KWR) pulled off in Q3 2026. Their net sales jumped to a solid $544.5 million, marking a 10% increase from the same quarter last year. Not bad for a company that had its...

Continue Reading

Top 5 Most Recently Viewed Articles

Medtronic's Sphere-360™ Catheter Receives CE Mark and US IDE Milestones

Updated Category News Views 160

Medtronic Achieves Major Milestones with Sphere-360™ Catheter In a significant development for the treatment of atrial fibrillation, Medtronic plc (NYSE: MDT) announced the receipt of the CE Mark for its Sphere-360™ single-shot pulsed field ablation (PFA) catheter. This innovative device is specifically designed to treat paroxysmal atrial fibrillation (AFib)...

Continue Reading
Oculis Holding AG Announces Participation in Investor Events

Updated Category News Views 178

Oculis Holding AG Engaging with Investors at Conferences Based in Switzerland, Oculis Holding AG (Nasdaq: OCS; Iceland: OCS) is a trailblazer in the biopharmaceutical industry, dedicated to pioneering treatments for ophthalmic and neuro-ophthalmic conditions. Today, Oculis is eager to convey its latest advancements at several prestigious upcoming investor conferences,...

Continue Reading
Freshpet CEO Implements Strategic Trading Plan for Shares

Updated Category News Views 159

Freshpet's Leadership Takes Initiative with Trading Plans Freshpet, Inc. (NASDAQ: FRPT), a leading name in fresh pet food, is making headlines as its Chief Executive Officer, Billy Cyr, shares his plans to adopt a Rule 10b5-1 trading strategy. This proactive approach is designed for the exercise of stock options that were granted back in 2016, with a looming expiration on...

Continue Reading
NOMAD Power Steps Into AI Energy Arena with Ticker NMAD

Updated Category News Views 14

From Reagents to Railways: The NOMAD Transformation Jumping straight from the lab to the electric grid, former biotech player LIXTE Biotechnology Holdings, Inc. has completed a dramatic pivot, emerging as NOMAD Power Solutions, Inc. (NASDAQ: NMAD). This isn't your everyday ticker change—it's a full-fledged identity overhaul that repositions them smack in the midst of AI...

Continue Reading
Novaturas Reports 2024 Half-Year Financial Performance

Updated Category News Views 93

Novaturas Reveals Half-Year Financial Results for 2024 On August 23, Kristijonas Kaikaris, the CEO of AB “Novaturas,” along with Interim CFO Auks? Kriau?i?nait?, presented the company's consolidated financial results for the first half of 2024 to investors. This report highlights the key financial indicators for Novaturas Group and its operations during this time...

Continue Reading